PAICON
ByteSight
Insights from Every Byte
Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: paicon.com
Gdzie słuchać?
Podcasty w aplikacji Replaio Radio Już wkrótcePodcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów
Odcinki
The Invisible Patient: Who Precision Medicine Actually Serves 30.06.2026 34:49
In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe speaks with Dr. Vinod Gauba , physician entrepreneur and Founder and CEO of GeneVault , about the invisible patient, the person whose biology was never reflected in the data shaping their own care. Drawing on a deeply personal experience with his father’s cancer treatment, Vinod explains why representation bias runs far deeper than ethnicity a...
The Translational Gap in Medicine: Why Discoveries Don’t Reach Patients 29.05.2026 26:43
In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe speaks with Dr. Christian Tidona , CEO of BioMed X , about why so many medical breakthroughs never reach patients, and what it actually takes to fix that. From the systemic reasons biotech startups fail, to clinical trials built on homogeneous populations, to the limits of black-box AI in drug development, Christian offers a candid, experience...
Rare Diseases, Missing Data, and the Limits of Modern Medicine 29.04.2026 26:04
In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe speaks with Faizan S. Mohammad , founder and CEO of Leg&airy , about the overlooked reality of rare diseases and what it will take to change it. Drawing on personal experience navigating the healthcare system for his son, Faizan challenges the very label "rare" when an estimated 300 million people globally live with these conditi...
AI as Data, Expertise as Insight in Life Sciences 27.02.2026 38:59
In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe speaks with Dr. Grant Coren , Managing Director of PharmaSearch Limited, about the evolving role of AI in life sciences. Together, they explore how artificial intelligence is reshaping drug discovery, clinical trials, and leadership in pharma, while confronting critical questions around data diversity, inclusion, and human expertise. From the...
From Data Chaos to Clinical Clarity: How Pharma Turns Messy Clinical & Omics Data into Decisions 29.01.2026 39:56
In this ByteSight episode, Dr. Manasi A-Ratnaparkhe speaks with Dr. Paul Agapow about why AI in biomedicine often gets the „right answer for the wrong reason.” Using the famous „wolf-husky problem,” they explore hidden correlations in medical data, why context matters as much as performance, and what it takes to move AI from pilot to real clinical impact. The conversation also dives into clinical...
When Policy Meets DNA: The Politics of Genomic Data 28.11.2025 40:34
In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe speaks with Simeón Baker , Executive Director of External Affairs at Genomics England, to explore what really happens when policy meets DNA. From newborn genome sequencing to national pharmacogenomics initiatives, the conversation goes far beyond science into ethics, governance, public trust, and the realities of building genomic programs at s...
The Last Mile of AI: Making Digital Pathology Work in Practice 30.10.2025 26:02
Most AI models perform beautifully in the lab but fail when faced with real-world complexity. In this episode of ByteSight, host Dr. Manasi A-Ratnaparkhe speaks with Dr. Heather Couture , Founder of Pixel Scientia Labs and host of the Impact AI podcast. Together, we explore why AI in digital pathology often fails to generalizeacross scanners, stains, and patient populations and what it really take...
Out of the Lab, Into the Living Room: The Future of Accessible Genomics 30.09.2025 31:05
In this episode of #ByteSight, our host Dr. Manasi A-Ratnaparkhe speaks with Dr. Catalina Lopez-Correa , Chief Global Strategy Officer at Genome Canada. Dr. CatalinaLopez-Correa is a globally recognized physician-scientist whose career spans pandemic preparedness, cancer research, and international health diplomacy. Together, we explore what it means to bring genomics „out of the lab and into the...
Genomic Equity Starts Here: Transforming Global Health Through African Genomics 28.08.2025 29:07
In this episode of ByteSight, Prof. Segun Fatumo explains why Africa’s genomic diversity is central to both understanding human evolution and shaping the future of global health. He reminds us that while most genomic research has focused on European populations, Africa remains the most genetically diverse continent, and excluding it means missing discoveries that could benefit everyone. Follow hi...
Genomics and the Path to Health Equity 17.07.2025 30:22
In this episode of ByteSight, we’re joined by Dr. Manuel Corpas , a Senior Lecturer in Genomics at the University of Westminster, Fellow of the Alan Turing Institute, and internationally recognized leader in genomics, bioinformatics, and health data science. Dr. Corpas shares his mission to make personalized medicine more accessible, especially in underrepresented populations. From leading the Spa...
AI in Healthcare: Between Hype and Hope 13.06.2025 30:23
In this episode of ByteSight, host Dr. Manasi A-Ratnaparkhe, co-founder and CEO of PAICON , sits down with with Dr. Rohit Thanki, an AI researcher with hands-on experience across India, Dubai, and Germany, to explore the complex reality of AI in healthcare. From the allure of AI models to the sobering challenges of data silos, regulatory bottlenecks, and lack of global applicability, Dr. Tanki sh...
From Slides to Systems: Building AI on Solid Data 20.05.2025 39:23
How do you build trustworthy AI in healthcare? Start with the data. In the first episode of ByteSight , host Dr. Manasi A-Ratnaparkhe, co-founder and CEO of PAICON , sits down with Dr. Uwe Schalles, a diagnostics veteran with 25+ years of experience at Roche and Ventana, to unpack the full data lifecycle from acquisition and curation to quality control and access for pharma R&D. Together, they...
Podobne podcasty
Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS